Global Anti-Infective Therapy Market Size, Status and Forecast 2020-2026

Global Anti-Infective Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Drug Type
1.3.1 Global Anti-Infective Therapy Market Size Growth Rate by Drug Type: 2020 VS 2026
1.3.2 Penicillin
1.3.3 Sulphonamides
1.3.4 Aminoglycosides
1.3.5 Fluoroquinolones
1.3.6 Antifungals
1.3.7 Antiprotozoal
1.3.8 Others
1.4 Market by Application
1.4.1 Global Anti-Infective Therapy Market Share by End Users: 2020 VS 2026
1.4.2 Home User
1.4.3 Hospitals/Clinics
1.4.4 Ambulatory Surgery Centres
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Infective Therapy Market Perspective (2015-2026)
2.2 Anti-Infective Therapy Growth Trends by Regions
2.2.1 Anti-Infective Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-Infective Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Anti-Infective Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Anti-Infective Therapy Industry Dynamic
2.3.1 Anti-Infective Therapy Market Trends
2.3.2 Anti-Infective Therapy Market Drivers
2.3.3 Anti-Infective Therapy Market Challenges
2.3.4 Anti-Infective Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Infective Therapy Players by Market Size
3.1.1 Global Top Anti-Infective Therapy Players by Revenue (2015-2020)
3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Infective Therapy Revenue
3.4 Global Anti-Infective Therapy Market Concentration Ratio
3.4.1 Global Anti-Infective Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Therapy Revenue in 2019
3.5 Key Players Anti-Infective Therapy Area Served
3.6 Key Players Anti-Infective Therapy Product Solution and Service
3.7 Date of Enter into Anti-Infective Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Infective Therapy Breakdown Data by Drug Type
4.1 Global Anti-Infective Therapy Historic Market Size by Drug Type (2015-2020)
4.2 Global Anti-Infective Therapy Forecasted Market Size by Drug Type (2021-2026)
5 Anti-Infective Therapy Breakdown Data by End Users
5.1 Global Anti-Infective Therapy Historic Market Size by End Users (2015-2020)
5.2 Global Anti-Infective Therapy Forecasted Market Size by End Users (2021-2026)
6 North America
6.1 North America Anti-Infective Therapy Market Size (2015-2026)
6.2 North America Anti-Infective Therapy Market Size by Drug Type (2015-2020)
6.3 North America Anti-Infective Therapy Market Size by End Users (2015-2020)
6.4 North America Anti-Infective Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Anti-Infective Therapy Market Size (2015-2026)
7.2 Europe Anti-Infective Therapy Market Size by Drug Type (2015-2020)
7.3 Europe Anti-Infective Therapy Market Size by End Users (2015-2020)
7.4 Europe Anti-Infective Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Therapy Market Size (2015-2026)
8.2 Asia-Pacific Anti-Infective Therapy Market Size by Drug Type (2015-2020)
8.3 Asia-Pacific Anti-Infective Therapy Market Size by End Users (2015-2020)
8.4 Asia-Pacific Anti-Infective Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Anti-Infective Therapy Market Size (2015-2026)
9.2 Latin America Anti-Infective Therapy Market Size by Drug Type (2015-2020)
9.3 Latin America Anti-Infective Therapy Market Size by End Users (2015-2020)
9.4 Latin America Anti-Infective Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Therapy Market Size (2015-2026)
10.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2015-2020)
10.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2015-2020)
10.4 Middle East & Africa Anti-Infective Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Abbott Laboratories Ltd.
11.1.1 Abbott Laboratories Ltd. Company Details
11.1.2 Abbott Laboratories Ltd. Business Overview
11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Introduction
11.1.4 Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2015-2020))
11.1.5 Abbott Laboratories Ltd. Recent Development
11.2 Cipla Ltd.
11.2.1 Cipla Ltd. Company Details
11.2.2 Cipla Ltd. Business Overview
11.2.3 Cipla Ltd. Anti-Infective Therapy Introduction
11.2.4 Cipla Ltd. Revenue in Anti-Infective Therapy Business (2015-2020)
11.2.5 Cipla Ltd. Recent Development
11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Introduction
11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2015-2020)
11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
11.4 Glenmark Pharmaceuticals Limited
11.4.1 Glenmark Pharmaceuticals Limited Company Details
11.4.2 Glenmark Pharmaceuticals Limited Business Overview
11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Introduction
11.4.4 Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2015-2020)
11.4.5 Glenmark Pharmaceuticals Limited Recent Development
11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Introduction
11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2015-2020)
11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
11.6 Lupin Limited
11.6.1 Lupin Limited Company Details
11.6.2 Lupin Limited Business Overview
11.6.3 Lupin Limited Anti-Infective Therapy Introduction
11.6.4 Lupin Limited Revenue in Anti-Infective Therapy Business (2015-2020)
11.6.5 Lupin Limited Recent Development
11.7 Panacea Biotec Limited
11.7.1 Panacea Biotec Limited Company Details
11.7.2 Panacea Biotec Limited Business Overview
11.7.3 Panacea Biotec Limited Anti-Infective Therapy Introduction
11.7.4 Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2015-2020)
11.7.5 Panacea Biotec Limited Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Anti-Infective Therapy Introduction
11.8.4 Novartis AG Revenue in Anti-Infective Therapy Business (2015-2020)
11.8.5 Novartis AG Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Anti-Infective Therapy Introduction
11.9.4 Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2015-2020)
11.9.5 Pfizer, Inc. Recent Development
11.10 Ranbaxy Laboratories Limited
11.10.1 Ranbaxy Laboratories Limited Company Details
11.10.2 Ranbaxy Laboratories Limited Business Overview
11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Introduction
11.10.4 Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2015-2020)
11.10.5 Ranbaxy Laboratories Limited Recent Development
11.11 Sun Pharmaceutical Industries Limited
10.11.1 Sun Pharmaceutical Industries Limited Company Details
10.11.2 Sun Pharmaceutical Industries Limited Business Overview
10.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Introduction
10.11.4 Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2015-2020)
10.11.5 Sun Pharmaceutical Industries Limited Recent Development
11.12 AstraZeneca plc
10.12.1 AstraZeneca plc Company Details
10.12.2 AstraZeneca plc Business Overview
10.12.3 AstraZeneca plc Anti-Infective Therapy Introduction
10.12.4 AstraZeneca plc Revenue in Anti-Infective Therapy Business (2015-2020)
10.12.5 AstraZeneca plc Recent Development
11.13 Johnson & Johnson
10.13.1 Johnson & Johnson Company Details
10.13.2 Johnson & Johnson Business Overview
10.13.3 Johnson & Johnson Anti-Infective Therapy Introduction
10.13.4 Johnson & Johnson Revenue in Anti-Infective Therapy Business (2015-2020)
10.13.5 Johnson & Johnson Recent Development
11.14 WOCKHARDT
10.14.1 WOCKHARDT Company Details
10.14.2 WOCKHARDT Business Overview
10.14.3 WOCKHARDT Anti-Infective Therapy Introduction
10.14.4 WOCKHARDT Revenue in Anti-Infective Therapy Business (2015-2020)
10.14.5 WOCKHARDT Recent Development
11.15 F. Hoffmann-La Roche Ltd
10.15.1 F. Hoffmann-La Roche Ltd Company Details
10.15.2 F. Hoffmann-La Roche Ltd Business Overview
10.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Introduction
10.15.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2015-2020)
10.15.5 F. Hoffmann-La Roche Ltd Recent Development
11.16 Sanofi
10.16.1 Sanofi Company Details
10.16.2 Sanofi Business Overview
10.16.3 Sanofi Anti-Infective Therapy Introduction
10.16.4 Sanofi Revenue in Anti-Infective Therapy Business (2015-2020)
10.16.5 Sanofi Recent Development
11.17 Merck
10.17.1 Merck Company Details
10.17.2 Merck Business Overview
10.17.3 Merck Anti-Infective Therapy Introduction
10.17.4 Merck Revenue in Anti-Infective Therapy Business (2015-2020)
10.17.5 Merck Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-Infective Therapy Market Size Growth Rate by Drug Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Penicillin
Table 3. Key Players of Sulphonamides
Table 4. Key Players of Aminoglycosides
Table 5. Key Players of Fluoroquinolones
Table 6. Key Players of Antifungals
Table 7. Key Players of Antiprotozoal
Table 8. Key Players of Others
Table 9. Global Anti-Infective Therapy Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 10. Global Anti-Infective Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Anti-Infective Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Anti-Infective Therapy Market Share by Regions (2015-2020)
Table 13. Global Anti-Infective Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Anti-Infective Therapy Market Share by Regions (2021-2026)
Table 15. Anti-Infective Therapy Market Market Trends
Table 16. Anti-Infective Therapy Market Drivers
Table 17. Anti-Infective Therapy Market Challenges
Table 18. Anti-Infective Therapy Market Restraints
Table 19. Global Anti-Infective Therapy Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Anti-Infective Therapy Market Share by Players (2015-2020)
Table 21. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2019)
Table 22. Global Anti-Infective Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-Infective Therapy Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 27. Global Anti-Infective Therapy Revenue Market Share by Drug Type (2015-2020)
Table 28. Global Anti-Infective Therapy Forecasted Market Size by Drug Type (2021-2026) (US$ Million)
Table 29. Global Anti-Infective Therapy Market Size Share by End Users (2015-2020) (US$ Million)
Table 30. Global Anti-Infective Therapy Revenue Market Share by End Users (2015-2020)
Table 31. Global Anti-Infective Therapy Forecasted Market Size by End Users (2021-2026) (US$ Million)
Table 32. North America Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 33. North America Anti-Infective Therapy Market Share by Drug Type (2015-2020)
Table 34. North America Anti-Infective Therapy Market Size by End Users (2015-2020) (US$ Million)
Table 35. North America Anti-Infective Therapy Market Share by End Users (2015-2020)
Table 36. North America Anti-Infective Therapy Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Anti-Infective Therapy Market Share by Country (2015-2020)
Table 38. Europe Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 39. Europe Anti-Infective Therapy Market Share by Drug Type (2015-2020)
Table 40. Europe Anti-Infective Therapy Market Size by End Users (2015-2020) (US$ Million)
Table 41. Europe Anti-Infective Therapy Market Share by End Users (2015-2020)
Table 42. Europe Anti-Infective Therapy Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Anti-Infective Therapy Market Share by Country (2015-2020)
Table 44. Asia-Pacific Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 45. Asia-Pacific Anti-Infective Therapy Market Share by Drug Type (2015-2020)
Table 46. Asia-Pacific Anti-Infective Therapy Market Size by End Users (2015-2020) (US$ Million)
Table 47. Asia-Pacific Anti-Infective Therapy Market Share by End Users (2015-2020)
Table 48. Asia-Pacific Anti-Infective Therapy Market Size by Region (US$ Million) (2015-2020)
Table 49. Asia-Pacific Anti-Infective Therapy Market Share by Region (2015-2020)
Table 50. Latin America Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 51. Latin America Anti-Infective Therapy Market Share by Drug Type (2015-2020)
Table 52. Latin America Anti-Infective Therapy Market Size by End Users (2015-2020) (US$ Million)
Table 53. Latin America Anti-Infective Therapy Market Share by End Users (2015-2020)
Table 54. Latin America Anti-Infective Therapy Market Size by Country (US$ Million) (2015-2020)
Table 55. Latin America Anti-Infective Therapy Market Share by Country (2015-2020)
Table 56. Middle East & Africa Anti-Infective Therapy Market Size by Drug Type (2015-2020) (US$ Million)
Table 57. Middle East & Africa Anti-Infective Therapy Market Share by Drug Type (2015-2020)
Table 58. Middle East & Africa Anti-Infective Therapy Market Size by End Users (2015-2020) (US$ Million)
Table 59. Middle East & Africa Anti-Infective Therapy Market Share by End Users (2015-2020)
Table 60. Middle East & Africa Anti-Infective Therapy Market Size by Country (US$ Million) (2015-2020)
Table 61. Middle East & Africa Anti-Infective Therapy Market Share by Country (2015-2020)
Table 62. Abbott Laboratories Ltd. Company Details
Table 63. Abbott Laboratories Ltd. Business Overview
Table 64. Abbott Laboratories Ltd. Anti-Infective Therapy Product
Table 65. Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 66. Abbott Laboratories Ltd. Recent Development
Table 67. Cipla Ltd. Company Details
Table 68. Cipla Ltd. Business Overview
Table 69. Cipla Ltd. Anti-Infective Therapy Product
Table 70. Cipla Ltd. Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 71. Cipla Ltd. Recent Development
Table 72. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
Table 73. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
Table 74. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product
Table 75. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 76. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
Table 77. Glenmark Pharmaceuticals Limited Company Details
Table 78. Glenmark Pharmaceuticals Limited Business Overview
Table 79. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product
Table 80. Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 81. Glenmark Pharmaceuticals Limited Recent Development
Table 82. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
Table 83. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
Table 84. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product
Table 85. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 86. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
Table 87. Lupin Limited Company Details
Table 88. Lupin Limited Business Overview
Table 89. Lupin Limited Anti-Infective Therapy Product
Table 90. Lupin Limited Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 91. Lupin Limited Recent Development
Table 92. Panacea Biotec Limited Company Details
Table 93. Panacea Biotec Limited Business Overview
Table 94. Panacea Biotec Limited Anti-Infective Therapy Product
Table 95. Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 96. Panacea Biotec Limited Recent Development
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Anti-Infective Therapy Product
Table 99. Novartis AG Company Details
Table 100. Novartis AG Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 101. Novartis AG Recent Development
Table 102. Pfizer, Inc. Company Details
Table 103. Pfizer, Inc. Business Overview
Table 104. Pfizer, Inc. Anti-Infective Therapy Product
Table 105. Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 106. Pfizer, Inc. Recent Development
Table 107. Ranbaxy Laboratories Limited Company Details
Table 108. Ranbaxy Laboratories Limited Business Overview
Table 109. Ranbaxy Laboratories Limited Anti-Infective Therapy Product
Table 110. Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 111. Ranbaxy Laboratories Limited Recent Development
Table 112. Sun Pharmaceutical Industries Limited Company Details
Table 113. Sun Pharmaceutical Industries Limited Business Overview
Table 114. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product
Table 115. Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 116. Sun Pharmaceutical Industries Limited Recent Development
Table 117. AstraZeneca plc Company Details
Table 118. AstraZeneca plc Business Overview
Table 119. AstraZeneca plc Anti-Infective Therapy Product
Table 120. AstraZeneca plc Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 121. AstraZeneca plc Recent Development
Table 122. Johnson & Johnson Company Details
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Anti-Infective Therapy Product
Table 125. Johnson & Johnson Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 126. Johnson & Johnson Recent Development
Table 127. WOCKHARDT Company Details
Table 128. WOCKHARDT Business Overview
Table 129. WOCKHARDT Anti-Infective Therapy Product
Table 130. WOCKHARDT Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 131. WOCKHARDT Recent Development
Table 132. F. Hoffmann-La Roche Ltd Company Details
Table 133. F. Hoffmann-La Roche Ltd Business Overview
Table 134. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product
Table 135. F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 136. F. Hoffmann-La Roche Ltd Recent Development
Table 137. Sanofi Company Details
Table 138. Sanofi Business Overview
Table 139. Sanofi Anti-Infective Therapy Product
Table 140. Sanofi Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 141. Sanofi Recent Development
Table 142. Merck Company Details
Table 143. Merck Business Overview
Table 144. Merck Anti-Infective Therapy Product
Table 145. Merck Revenue in Anti-Infective Therapy Business (2015-2020) (US$ Million)
Table 146. Merck Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Infective Therapy Market Share by Drug Type: 2020 VS 2026
Figure 2. Penicillin Features
Figure 3. Sulphonamides Features
Figure 4. Aminoglycosides Features
Figure 5. Fluoroquinolones Features
Figure 6. Antifungals Features
Figure 7. Antiprotozoal Features
Figure 8. Others Features
Figure 9. Global Anti-Infective Therapy Market Share by End Users: 2020 VS 2026
Figure 10. Home User Case Studies
Figure 11. Hospitals/Clinics Case Studies
Figure 12. Ambulatory Surgery Centres Case Studies
Figure 13. Others Case Studies
Figure 14. Anti-Infective Therapy Report Years Considered
Figure 15. Global Anti-Infective Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 16. Global Anti-Infective Therapy Market Share by Regions: 2020 VS 2026
Figure 17. Global Anti-Infective Therapy Market Share by Regions (2021-2026)
Figure 18. Global Anti-Infective Therapy Market Share by Players in 2019
Figure 19. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2019
Figure 21. North America Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. United States Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Canada Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Europe Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Germany Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. France Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. U.K. Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Italy Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Russia Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Nordic Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Asia-Pacific Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. China Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Japan Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. South Korea Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Southeast Asia Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. India Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Australia Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Asia-Pacific Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Latin America Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Middle East & Africa Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Anti-Infective Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Abbott Laboratories Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 47. Cipla Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 48. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 49. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 50. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 51. Lupin Limited Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 52. Panacea Biotec Limited Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 53. Novartis AG Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 54. Pfizer, Inc. Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 55. Ranbaxy Laboratories Limited Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 56. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 57. AstraZeneca plc Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 58. Johnson & Johnson Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 59. WOCKHARDT Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 61. Sanofi Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 62. Merck Revenue Growth Rate in Anti-Infective Therapy Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs